Bone Biologics Corporation (BBLG)

NASDAQ: BBLG · IEX Real-Time Price · USD
-0.15 (-5.03%)
At close: Jan 21, 2022 4:00 PM
0.17 (6.01%)
After-hours:Jan 21, 2022 7:51 PM EST

Total Valuation

Bone Biologics has a market cap or net worth of $29.29 million. The enterprise value is $42.06 million.

Market Cap29.29M
Enterprise Value42.06M

Important Dates

Earnings Daten/a
Ex-Dividend DateOct 13, 2021

Share Statistics

Bone Biologics has 10.35 million shares outstanding.

Shares Outstanding10.35M
Shares Change (YoY)n/a
Shares Change (QoQ)0.00%
Owned by Insiders (%)70.04%
Owned by Institutions (%)n/a

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
PB Ration/a
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

EV / Earningsn/a
EV / Salesn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 0.00, with a Debt / Equity ratio of n/a.

Current Ratio0.00
Quick Ratio0.00
Debt / Equityn/a
Debt / EBITDAn/a
Debt / FCFn/a

Financial Efficiency

Return on Equity (ROE)n/a
Return on Assets (ROA)-5,896.00%
Return on Capital (ROIC)n/a
Revenue Per Employeen/a
Profits Per Employee-$1.89M
Employee Count1
Asset Turnovern/a
Inventory Turnovern/a


Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

. The beta is -0.21, so Bone Biologics's price volatility has been lower than the market average.

Beta (1Y)-0.21
52-Week Price Changen/a
50-Day Moving Average3.62
200-Day Moving Average3.96
Average Volume (30 Days)1,715,951

Short Selling Information

Short Interest35,941
Short % of Shares Out0.35%
Short % of Float1.16%
Short Ratio (days to cover)0.16

Income Statement

Gross Profitn/a
Operating Income-849,026
Net Income-1.89M
Earnings Per Share (EPS)-$0.15
Full Income Statement

Balance Sheet

The company has $3,374 in cash and $12.77 million in debt, giving a net cash position of -$12.76 million or -$1.23 per share.

Cash & Cash Equivalents3,374
Total Debt12.77M
Net Cash-12.76M
Net Cash Per Share-$1.23
Book Value-15.13M
Book Value Per Share-1.46
Working Capital-15.13M
Full Balance Sheet

Cash Flow

Operating Cash Flow-1.17M
Capital Expendituresn/a
Free Cash Flow-1.17M
FCF Per Sharen/a
Full Cash Flow Statement


Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Bone Biologics does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-6.44%
FCF Yield-3.99%
Dividend Growth (YoY)n/a
Payout Ration/a

Stock Splits

The last stock split was on October 13, 2021. It was a reverse split with a ratio of 1:2.

Last Split DateOct 13, 2021
Split TypeReverse
Split Ratio1:2